|
Q3 2017
Filed on Aug 30, 2024
|
28,900
|
$56.94 - $61.26
$1.65M - $1.77M
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
1,112
|
$32.65 - $37.9
$36.3K - $42.1K
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
14,119
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
11,392
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
4,010
|
N/A
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
818
|
N/A
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
3,000
|
$2.24 - $3.11
$6.72K - $9.33K
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
11
|
N/A
|
|
Arena Pharmaceuticals Inc
|
Q4 2017
Filed on Aug 30, 2024
|
25
|
N/A
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
400
|
N/A
|
|
Blue Buffalo Pet Prods Inc
|
Q1 2018
Filed on Aug 30, 2024
|
80
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
500
|
$15.38 - $23.91
$7.69K - $12K
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
150
|
N/A
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
500
|
N/A
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
290
|
$106.2 - $124.55
$30.8K - $36.1K
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
500
|
$1.55 - $2.3
$775 - $1.15K
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
3,660
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
1,400
|
N/A
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
1,000
|
$22.34 - $25.79
$22.3K - $25.8K
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
1,250
|
$16.3 - $18.18
$20.4K - $22.7K
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
460
|
$34.38 - $40.23
$15.8K - $18.5K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
6,000
|
$3.89 - $4.17
$23.3K - $25K
|
|
Peregrine Pharmaceuticals In
|
Q1 2018
Filed on Aug 30, 2024
|
162
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
2,000
|
$11.12 - $11.98
$22.2K - $24K
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
2,500
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
51,300
|
N/A
|
|
Powershares Global ETF Fd
|
Q2 2018
Filed on Aug 30, 2024
|
11,340
|
N/A
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
20
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
818,118
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
167
|
$18.63 - $21.9
$3.11K - $3.66K
|
|
Social Cap Hedosophia Hldgs
|
Q1 2018
Filed on Aug 30, 2024
|
5,000
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
275
|
$21.32 - $21.95
$5.86K - $6.04K
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
1,500
|
$12.99 - $14.16
$19.5K - $21.2K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
31,161
|
$9.53 - $15.68
$297K - $489K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
8,570
|
$48.45 - $55.08
$415K - $472K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
1,850
|
$44.25 - $54.6
$81.9K - $101K
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
2,755
|
$5.11 - $8.06
$14.1K - $22.2K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
1,381
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
11,132
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
2,970
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
8,490
|
$4.09 - $5.96
$34.7K - $50.6K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
2,628
|
N/A
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
23,713
|
$1.89 - $4.95
$44.8K - $117K
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
7,000
|
$3.22 - $6.33
$22.5K - $44.3K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
7,189
|
$8.45 - $9.68
$60.7K - $69.6K
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
20,683
|
$42.55 - $53.5
$880K - $1.11M
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
5,574
|
$20.08 - $22.46
$112K - $125K
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
9,506
|
$36.1 - $41.05
$343K - $390K
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
4,200
|
$18.99 - $25.93
$79.8K - $109K
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
4,000
|
N/A
|
|